Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05253755 · ClinicalTrials.gov registry record · Phase 2
Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
A Phase 2 study, sponsored by DermBiont.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT05253755: Clinical Trial Phase 2 study, sponsored by DermBiont.
NCT05253755 is a Phase 2 study that was terminated before completion, run by DermBiont. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05253755, a Phase 2 study, was terminated before completion, sponsored by DermBiont.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose for this study is to assess the Safety and Efficacy of Daily Application for 4 weeks of DBI-001 Gel Versus Aqueous Gel in Subjects with Atopic Dermatitis
Primary Outcome
Change from baseline in individual signs and symptoms of Atopic Dermatitis (components of the ADSI score) at days 7, 14, 21, 28, 35, and 42 of sites treated with DBI-001 Gel or Aqueous Gel Atopic Dermatitis Severity Index: The ADSI score represents the sum of the individual severity scores of none, mild, moderate, or severe for the following component signs and symptoms: erythema, pruritus, exudation, excoriation, and lichenification. To calculate the ADSI score, the component scores are added t
Interventions
- BIOLOGICAL DBI-001
- BIOLOGICAL Aqueous gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2022-09-09 |
| Phase | Phase 2 |
Why NCT05253755 stopped before completion
NCT05253755 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which DBI-001 is the first listed.
NCT05253755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05253755 about?
NCT05253755 is a clinical study titled "Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel". The purpose for this study is to assess the Safety and Efficacy of Daily Application for 4 weeks of DBI-001 Gel Versus Aqueous Gel in Subjects with Atopic Dermatitis
What is the current status of trial NCT05253755?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2021-10-06. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT05253755?
The interventions under investigation include: DBI-001 (BIOLOGICAL), Aqueous gel (BIOLOGICAL).
Who is sponsoring clinical trial NCT05253755?
This trial is sponsored by DermBiont, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05253755's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI